Blaser K
Swiss Institute of Allergy and Asthma Research (SIAF), Davos, Switzerland.
Adv Exp Med Biol. 1996;409:295-303. doi: 10.1007/978-1-4615-5855-2_42.
The elicitation of a specific immune response against allergens depends on the recognition of antigenic determinants (epitopes) by specific T and B lymphocytes. In order to determine the relevant epitopes for human T and B cells and their features in the regulation and production of specific IgE and/or IgG antibodies, we have investigated the immune response to bee venom phospholipase A2 (PLA) in allergic and non-allergic subjects. This enzyme represents the major allergen in bee sting allergy. It consists of 134 amino acid residues with a carbohydrate side chain at position 13 and is available as recombinant protein. We have developed PLA-specific T-cell clones from bee sting allergic and non-allergic human subjects. Using a panel of dodecapeptides overlapping in 10 residues and a large set of 18-25 mer overlapping peptides, we detected three epitopes that were recognized by peripheral blood T-cells and T-cell clones. A fourth determinant involved the carbohydrate moiety on Asn13 of PLA. Whereas the CHO-depending epitope seems to be mostly active in allergics, the other three epitopes are equally recognized by peripheral blood mononuclear cells (PBMC) of both allergic and non-allergic individuals. In T-cell clones, the ratio of IL-4/IFN gamma cytokines and the quality of the activating signal depend on the strength of the binding of the MHC-II/Ag/TcR complex between APC and T-cells. The number of antigen-specific APC-T-cell contact sites can be varied in vitro by changing the dose of antigen added to the cell culture. While isotype switch for both IgE and IgG4 requires IL-4, this cytokine suppresses antigen-specific IgG4 production by already switched B-cells. Therefore, IL-4 and IFN gamma display counter-regulatory effects on the production of IgE being responsible for atopic states and IgG4 antibodies which are signs of a normal immune response to allergen and act as protective antibodies. The combination of this counter-regulation of IgE and IgG4 antibodies with the fundamental law of mass action for chemical equilibrium reactions revealed that the antigen concentration governs to a great part the ratio of IL-4/IFN gamma secretion and therefore the formation of IgE and IgG and allergy or protection, together with the equilibrium constant K, which represents immunological individuality and a measure of Ag presentation.
针对过敏原引发特异性免疫反应取决于特异性T淋巴细胞和B淋巴细胞对抗原决定簇(表位)的识别。为了确定人类T细胞和B细胞的相关表位及其在特异性IgE和/或IgG抗体调节与产生中的特征,我们研究了过敏和非过敏受试者对蜂毒磷脂酶A2(PLA)的免疫反应。这种酶是蜂蜇过敏中的主要过敏原。它由134个氨基酸残基组成,在第13位带有碳水化合物侧链,并且有重组蛋白形式。我们从蜂蜇过敏和非过敏的人类受试者中培养出了PLA特异性T细胞克隆。使用一组在10个残基处重叠的十二肽和一大组18 - 25个氨基酸残基重叠的肽段,我们检测到了三个可被外周血T细胞和T细胞克隆识别的表位。第四个决定簇涉及PLA第13位天冬酰胺上的碳水化合物部分。虽然依赖碳水化合物的表位似乎在过敏者中大多具有活性,但其他三个表位在过敏和非过敏个体的外周血单个核细胞(PBMC)中均能被同等识别。在T细胞克隆中,IL - 4/IFNγ细胞因子的比例以及激活信号的质量取决于抗原呈递细胞(APC)与T细胞之间MHC - II/抗原/T细胞受体复合物的结合强度。通过改变添加到细胞培养物中的抗原剂量,体外可改变抗原特异性APC - T细胞接触位点的数量。虽然IgE和IgG4的同种型转换都需要IL - 4,但这种细胞因子会抑制已发生转换的B细胞产生抗原特异性IgG4。因此,IL - 4和IFNγ对特应性状态所涉及的IgE产生以及IgG4抗体产生具有相反的调节作用,IgG4抗体是对过敏原正常免疫反应的标志,并起保护性抗体的作用。IgE和IgG4抗体的这种反向调节与化学平衡反应的质量作用基本定律相结合表明,抗原浓度在很大程度上决定了IL - 4/IFNγ分泌的比例,进而决定了IgE和IgG的形成以及过敏或保护状态,同时还与代表免疫个体性和抗原呈递量度的平衡常数K有关。